Suppr超能文献

补充和替代医学干预试验中的方法学问题。

Methodological issues in trials of complementary and alternative medicine interventions.

作者信息

Sikorskii Alla, Wyatt Gwen, Victorson David, Faulkner Gwen, Rahbar Mohammad Hossein

机构信息

Department of Statistics and Probability, College of Natural Science, Michigan State University, East Lansing, MI, 48824, USA.

出版信息

Nurs Res. 2009 Nov-Dec;58(6):444-51. doi: 10.1097/NNR.0b013e3181bf15fe.

Abstract

BACKGROUND

Complementary and alternative medicine (CAM) use is widespread among cancer patients. Information on safety and efficacy of CAM therapies is needed for both patients and healthcare providers. Well-designed randomized clinical trials of CAM therapy interventions can inform both clinical research and practice.

OBJECTIVES

The aim of this study was to review important issues that affect the design of randomized clinical trials for CAM interventions.

METHODS

Using the methods component of the Consolidated Standards for Reporting Trials as a guiding framework and a National Cancer Institute-funded reflexology study as an exemplar, methodological issues related to participants, intervention, objectives, outcomes, sample size, randomization, blinding, and statistical methods were reviewed.

DISCUSSION

Trials of CAM interventions designed and implemented according to appropriate methodological standards will facilitate the needed scientific rigor in CAM research. Interventions in CAM can be tested using proposed methodology, and the results of testing will inform nursing practice in providing safe and effective supportive care and in improving the well-being of patients.

摘要

背景

补充和替代医学(CAM)在癌症患者中广泛使用。患者和医疗服务提供者都需要有关CAM疗法安全性和有效性的信息。精心设计的CAM疗法干预随机临床试验可为临床研究和实践提供参考。

目的

本研究的目的是回顾影响CAM干预随机临床试验设计的重要问题。

方法

以《报告试验的统一标准》的方法部分为指导框架,并以一项由美国国立癌症研究所资助的反射疗法研究为例,对与参与者、干预措施、目标、结局、样本量、随机化、盲法和统计方法相关的方法学问题进行了回顾。

讨论

根据适当的方法学标准设计和实施的CAM干预试验将有助于在CAM研究中实现所需的科学严谨性。CAM中的干预措施可以使用所提出的方法进行测试,测试结果将为护理实践提供信息,以提供安全有效的支持性护理并改善患者的健康状况。

相似文献

1
Methodological issues in trials of complementary and alternative medicine interventions.
Nurs Res. 2009 Nov-Dec;58(6):444-51. doi: 10.1097/NNR.0b013e3181bf15fe.
2
A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
3
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Future direction of complementary and alternative medicine (CAM) education and research.
Semin Oncol Nurs. 2005 Aug;21(3):215-24. doi: 10.1016/j.soncn.2005.04.011.
9
Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.
J Clin Epidemiol. 2006 Dec;59(12):1257-65. doi: 10.1016/j.jclinepi.2006.03.006. Epub 2006 Jul 3.
10
Complementary therapies for acne vulgaris.
Cochrane Database Syst Rev. 2015 Jan 19;1(1):CD009436. doi: 10.1002/14651858.CD009436.pub2.

引用本文的文献

1
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan.
Curr Oncol Rep. 2024 Nov;26(11):1321-1333. doi: 10.1007/s11912-024-01595-6. Epub 2024 Oct 3.
2
A Pilot Study of Medical Misinformation Perceptions and Training Among Practitioners in North Carolina (USA).
Inquiry. 2021 Jan-Dec;58:469580211035742. doi: 10.1177/00469580211035742.
4
Themes Underlying Australian General Practitioner Views towards Chiropractic and Osteopathy: An Assessment of Free Text Data from a Cross-Sectional Survey.
Evid Based Complement Alternat Med. 2018 Jan 14;2018:2786106. doi: 10.1155/2018/2786106. eCollection 2018.
7
Concordance between patient reports of cancer-related symptoms and medical records documentation.
J Pain Symptom Manage. 2012 Sep;44(3):362-72. doi: 10.1016/j.jpainsymman.2011.09.017. Epub 2012 Jun 13.

本文引用的文献

1
Recruitment and early retention of women with advanced breast cancer in a complementary and alternative medicine trial.
Evid Based Complement Alternat Med. 2011;2011:734517. doi: 10.1093/ecam/nep051. Epub 2011 Feb 14.
2
Response analysis for multiple symptoms revealed differences between arms of a symptom management trial.
J Clin Epidemiol. 2009 Jul;62(7):716-24. doi: 10.1016/j.jclinepi.2008.09.007. Epub 2009 Jan 4.
4
Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.
Support Care Cancer. 2009 May;17(5):563-72. doi: 10.1007/s00520-008-0528-8. Epub 2008 Nov 13.
5
Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?
Evid Based Complement Alternat Med. 2009 Mar;6(1):19-30. doi: 10.1093/ecam/nem121. Epub 2007 Oct 4.
6
Symptom burden after autologous stem cell transplantation for multiple myeloma.
Cancer. 2008 Apr 1;112(7):1617-24. doi: 10.1002/cncr.23299.
8
Symptom burden: multiple symptoms and their impact as patient-reported outcomes.
J Natl Cancer Inst Monogr. 2007(37):16-21. doi: 10.1093/jncimonographs/lgm005.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验